The Endocannabinoid System Explained

The body-wide signaling network behind how cannabinoids work.

To understand how cannabis and cannabinoids affect the body, it helps to start with the system they act on: the endocannabinoid system, or ECS. Identified by researchers in the early 1990s across a series of discoveries, the ECS turned out to be a major regulatory network — one the body uses to help keep a wide range of processes in balance, including pain sensation, mood, and appetite. That broad reach is exactly why cannabinoid-based therapies are being studied for so many different conditions.

The Two Main Receptors: CB1 and CB2

The best-understood components of the ECS are two receptors: CB1 and CB2. Receptors act like locks that specific molecules — the body's own cannabinoids, or those from cannabis — can fit into, triggering a response.

CB1 receptors are found mainly in the central nervous system, especially the brain and spinal cord. They help regulate neurological functions such as memory, cognition, motor control, and pain perception. When a cannabinoid like THC activates CB1 receptors, the result can include psychoactive effects — the “high” — alongside therapeutic effects such as pain relief and appetite stimulation.

CB2 receptors are found mostly in peripheral tissues, particularly within the immune system and the gastrointestinal tract. They are involved in modulating immune responses and inflammation. Importantly, unlike CB1, activating CB2 receptors does not produce psychoactive effects. Instead, CB2 helps regulate processes like immune cell movement and inflammatory responses — which is why these receptors are of interest as a target for inflammatory and autoimmune conditions.

Beyond CB1 and CB2: The Wider Cast

The ECS is more than just its two classical receptors. Cannabinoids also interact with several other receptors that influence a broad range of physiological processes — including the TRPV1 and TRPV2 ion channels and a group of G-protein coupled receptors known as GPR18, GPR55, and GPR119.

TRPV1 and TRPV2

TRPV1, sometimes called the capsaicin receptor — it's the one activated by the “heat” of chili peppers — responds to heat and pain and is involved in inflammation and pain perception. It can be activated by endocannabinoids such as anandamide, which helps modulate pain signaling. TRPV2 is less well understood, but it responds to mechanical and osmotic pressure and plays a role in immune responses.

GPR18, GPR55, and GPR119

GPR18 is involved in immune response and pain regulation, can be activated by cannabinoids, and may influence immune cell migration and intraocular (eye) pressure. GPR55 — sometimes nicknamed the “orphan cannabinoid receptor” — is associated with bone density regulation, inflammation, and is being studied for a possible role in cancer cell proliferation. GPR119, found mainly in the pancreas and gastrointestinal tract, is linked to glucose metabolism and insulin release and can be influenced by cannabinoid-like compounds.

Why This Matters

Together, these receptors extend the ECS's influence well beyond what the two classical receptors alone would suggest — reaching into pain, immune function, metabolism, and inflammation. Their interaction with cannabinoids is part of why researchers see potential for cannabinoid-based approaches across conditions as varied as chronic pain, inflammatory diseases, and metabolic disorders. As the science advances, these receptors may become valuable targets for new treatments. For now, understanding the ECS simply helps explain why a single plant compound can have such wide-ranging effects on the body — and why those effects differ so much depending on which receptors are involved.

This article is for general educational information only and is not medical advice. Please consult a qualified healthcare professional for guidance on cannabis and your individual health.